Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It is not appropriate for buyers expecting FDA-approved outcomes, competitive athletes subject to WADA testing, or anyone seeking treatment for a medical condition
Most people use it as a small subcutaneous injection 30 to 60 minutes before intimacy
Companies cannot legally market it for human consumption but may sell it as a research chemical
Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)
US$ 22.06
US$ 26.77
US$ 23.90
US$ 23.19
US$ 27.56
US$ 21.31
US$ 26.68
US$ 28.63
US$ 26.87
US$ 27.64
US$ 24.24
US$ 27.27
US$ 21.17
US$ 29.12
